Siltuximab as a first-line therapy for idiopathic multicentric Castleman disease: a retrospective analysis based on the SiMuLa study of the Italian regional network
西妥昔单抗作为特发性多中心性卡斯尔曼病的一线治疗:基于意大利区域网络SiMuLa研究的回顾性分析
期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2026.1762473
Pelliccia, S; Di Rocco, A; Palumbo, G; Zizzari, A; Annibali, O; Maiolo, E; Rago, A; Trapè, G; Bianchi, M P; Pileggi, G; Filomeno, L; Hohaus, S; Rigacci, L; Cox, M C; Martelli, M; La Verde, G; Di Napoli, A; Tafuri, A